ATHN 9: Severe VWD Natural History Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Angela Weyand, MD
University of Michigan Hemophilia and Coagulation Disorders
Principal Investigator - Robert Sidonio, MD
Emory University / Children's Healthcare of Atlanta
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Center for Inherited Blood Disorders
Orange, California, United States
- University of Colorado Denver Hemophilia and Thrombosis Center
Aurora, Colorado, United States
- Connecticut Bleeding and Clotting Disorders Center
Farmington, Connecticut, United States
- University of Florida Hemophilia Treatment Center
Gainesville, Florida, United States
- Children'S Healthcare of Atlanta/emory
Atlanta, Georgia, United States
- Bleeding and Clotting Disorders Institute
Peoria, Illinois, United States
- Indiana Hemophilia and Thrombosis Center (ihtc)
Indianapolis, Indiana, United States
- Louisiana Center for Bleeding and Clotting Disorders
New Orleans, Louisiana, United States
- University of Michigan Hemophilia and Coagulation Disorders
Ann Arbor, Michigan, United States
- Children'S Hospital of Michigan Hemostasis and Thrombosis Center
Detroit, Michigan, United States
- Michigan State University Center for Bleeding and Clotting Disorders
East Lansing, Michigan, United States
- Mayo Comprehensive Hemophilia Center
Rochester, Minnesota, United States
- Washington University Center for Treatment of Bleeding and Blood Clotting Disorders
St Louis, Missouri, United States
- Nationwide Children'S Hospital Columbus
Columbus, Ohio, United States
- Oregon Health
Portland, Oregon, United States
- Pennsylvania Comprehensive Hemophilia and Thrombophilia Program / Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Hemophilia Center of Western Pennsylvania
Pittsburgh, Pennsylvania, United States
- Rhode Island Hemostasis & Thrombosis Center
Providence, Rhode Island, United States
- University of Tennessee, University Clinical Health (memphis)
Memphis, Tennessee, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Hemophilia Outreach Center
Green Bay, Wisconsin, United States
- Versiti - Blood Center of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Jun 2019
- Primary completion
- 31 Dec 2025
- Completion
- 30 Jul 2026
- Last update posted
- 12 Mar 2025
- Registered enrollment
- 108
- Registry id
- NCT03853486
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.